Detalles de la búsqueda
1.
Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer's disease.
Behav Pharmacol
; 28(2 and 3-Spec Issue): 124-131, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28125507
2.
Expanding the multipotent profile of huprine-tacrine heterodimers as disease-modifying anti-Alzheimer agents.
Neurodegener Dis
; 10(1-4): 96-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22236498
3.
Clock/Sleep-Dependent Learning and Memory in Male 3xTg-AD Mice at Advanced Disease Stages and Extrinsic Effects of Huprine X and the Novel Multitarget Agent AVCRI104P3.
Brain Sci
; 11(4)2021 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33810622
4.
Effect of huprine X on ß-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Neurodegener Dis
; 7(6): 379-88, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20689242
5.
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
J Med Chem
; 55(2): 661-9, 2012 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22185619
6.
Novel huprine derivatives with inhibitory activity toward ß-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
ChemMedChem
; 5(11): 1855-70, 2010 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-20859987
Resultados
1 -
6
de 6
1
Próxima >
>>